European Respiratory Society

Patients' perspectives on COPD: findings from a social media listening study
Cough, mucus and dyspnoea are the most frequently discussed symptoms on social media by patients with COPD
Triple therapy (ICS/LABA/LAMA) in COPD: thinking out of the box
Triple inhaler therapy in COPD might in some real-life situations be useful outside of the strict indications reported by the registration agencies, but at the same time in some other situations it could be better avoided, even when recommended
Biomarkers for tuberculosis: the case for lipoarabinomannan
There is a high potential for a urinary LAM-based point-of-care test to diagnose TB. Markers for host response to LAM should be explored to identify those at highest risk of developing active TB.
Pulmonary veno-occlusive disease is highly prevalent in scleroderma patients undergoing lung transplantation
There is an unexpectedly high incidence of PVOD in patients with SSc-PH-ILD. Presence of PVOD may be an unrecognised contributor to the dismal prognosis of these patients. Early transplant referral should be considered for those with SSc-PH-ILD.
IQOS exposure impairs human airway cell homeostasis: direct comparison with traditional cigarette and e-cigarette
Heated tobacco devices can alter vital physiological functions in the lung. HNBs may not be a safer option than cigarette smoking or eCig vaping; this does not support the recommendation of their use over other nicotine delivery products.

Latest Articles

European Respiratory Society International Congress, Paris, 2018: highlights from the Clinical Assembly
Lowie E.G.W. Vanfleteren, Iñigo Ojanguren, Claire M. Nolan, Frits M.E. Franssen, Vasileios Andrianopoulos, Aleksandar Grgic, Marlies van Dijk, Dirk Jan Slebos, Luke Daines, Janwillem W.H. Kocks, Nicolas Kahn

ERJ Open Research Feb 2019, 5 (1) 00176-2018; DOI: 10.1183/23120541.00176-2018
Biomarkers for tuberculosis: the case for lipoarabinomannan
Margarida Correia-Neves, Gabrielle Fröberg, Liudmyla Korshun, Sofia Viegas, Paula Vaz, Nehaben Ramanlal, Judith Bruchfeld, Beston Hamasur, Patrick Brennan, Gunilla Källenius

ERJ Open Research Feb 2019, 5 (1) 00115-2018; DOI: 10.1183/23120541.00115-2018
Triple therapy (ICS/LABA/LAMA) in COPD: thinking out of the box
Lowie E.G.W. Vanfleteren, Anders Ullman, Anita Nordenson, Anders Andersson, Kristina Andelid, Leonardo M. Fabbri

ERJ Open Research Feb 2019, 5 (1) 00185-2018; DOI: 10.1183/23120541.00185-2018
IQOS exposure impairs human airway cell homeostasis: direct comparison with traditional cigarette and e-cigarette
Sukhwinder Singh Sohal, Mathew Suji Eapen, Vegi G.M. Naidu, Pawan Sharma

ERJ Open Research Feb 2019, 5 (1) 00159-2018; DOI: 10.1183/23120541.00159-2018
Pulmonary veno-occlusive disease is highly prevalent in scleroderma patients undergoing lung transplantation
Shikha Gupta, Aman Gupta, Sofiya Rehman, Iclal Ocak, Robyn T. Domsic, Frank Schneider, M. Patricia George

ERJ Open Research Feb 2019, 5 (1) 00168-2018; DOI: 10.1183/23120541.00168-2018
Patients' perspectives on COPD: findings from a social media listening study
Nigel S. Cook, Konstantinos Kostikas, Jean-Bernard Gruenberger, Bhavik Shah, Purnima Pathak, Vinay Preet Kaur, Alaknanda Mudumby, Rajat Sharma, Florian S. Gutzwiller

ERJ Open Research Feb 2019, 5 (1) 00128-2018; DOI: 10.1183/23120541.00128-2018

About ERJ Open Research

ERJ Open Research is a new fully open access original research journal, published online by the European Respiratory Society. The journal aims to publish high-quality work in all fields of respiratory science and medicine, covering basic science, clinical translational science and clinical medicine.

Tweets by @ERSpublications

Main menu

User menu

Search

Latest Articles

About ERJ Open Research